🇺🇸 FDA
Patent

US 6242482

Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure

expired A61KA61K31/192A61K31/222

Quick answer

US patent 6242482 (Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure) held by United Therapeutics Corporation expires Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Jun 05 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
51
CPC classes
A61K, A61K31/192, A61K31/222, A61K31/5585, A61K47/60